Pomelo Care vs Thermo Fisher Scientific
Side-by-side comparison of AI visibility scores, market position, and capabilities
Pomelo Care hit $1.7B unicorn ($92M Series C, Jan 2026) covering ~7% of US births (25M+ lives) with peer-reviewed results: 37% fewer preterm births, 46% lower ER utilization.
About
Pomelo Care is a New York-based virtual maternity and women's health company that raised $92 million in Series C funding in January 2026, reaching a $1.7 billion unicorn valuation. The round was led by Stripes with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel. Founded in 2021, Pomelo now supports nearly 7 percent of all U.S. births.
Thermo Fisher (TMO) reported $42.9B revenue in FY2024, down 1% YoY. World's #1 life sciences company. Serves pharma, biotech, labs globally. ~100,000 employees. HQ: Waltham, MA.
About
Thermo Fisher Scientific Inc. is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services to researchers, healthcare organizations, and industrial companies. Headquartered in Waltham, Massachusetts, Thermo Fisher was formed through the 2006 merger of Thermo Electron and Fisher Scientific and has since grown aggressively through acquisitions. The company reported revenues of $42.9B in FY2024, slightly down year-over-year after exceptional COVID-related revenue in 2021–2022.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.